Company facts
- Headquarters
- Eagan, Minnesota
- Most recent report
- 10-Q, filed Nov 5, 2026
- Incorporated
- Delaware
- Filings on record
- 263 filings
- On EDGAR
- CIK 1964738
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 11
News 8 of 33
Prospectuses and Registrations 6
- FWP Free writing prospectus Aug 13, 2025
- S-3ASR Automatic shelf registration Aug 13, 2025
- POS AM Post-effective amendment to a registration Dec 11, 2024
- 424B3 Prospectus supplement for an offering Dec 2, 2024
- S-4 Registration statement for a merger or exchange Nov 15, 2024
- S-8 Registration statement for an employee plan Apr 1, 2024
Proxies 4
Ownership 8 of 164
- 4 Insider reported a trade Sep 3, 2026
- 4 Insider reported a trade Aug 18, 2026
- 3 Insider reported their initial holding Aug 18, 2026
- 4 Insider reported a trade May 18, 2026
- 4 Insider reported a trade May 18, 2026
- 4 Insider reported a trade May 18, 2026
- 4 Insider reported a trade May 18, 2026
- 4 Insider reported a trade May 18, 2026
Other 8 of 45
- SD Conflict minerals disclosure May 29, 2026
- 424B7 Aug 14, 2025
- 424B7 Aug 14, 2025
- SD Conflict minerals disclosure May 30, 2025
- ARS Annual report sent to shareholders Mar 21, 2025
- IRANNOTICE Notice of Iran-related activity Feb 28, 2025
- EFFECT Notice that a registration became effective Dec 17, 2024
- EFFECT Notice that a registration became effective Dec 2, 2024
What to read: Sep 2026 10-Q
SECSift found 3 of 13 sections worth reading, with 0 positive, 5 notable, and 1 negative flags.
Financial Statements (Item 1)
Balance sheet shows cash halved, debt due, and a $204M legal charge in Q3 2026.Management's Discussion (Item 2)
Dense MD&A: segment results, tariff refunds, ERP disruption, and a planned business separation.NotableRisk Factors (Item 1A)
New risk factor: strategic review of health information systems business may fail or distract.
What changed: Sep 2026 vs. Jun 2026
About 6% of SOLV's Sep 2026 10-Q is new information. 20 paragraphs were added, 137 changed, and 25 removed. Below are the most important lines SECSift identified.
New
- Added corrected deadline of February 12, 2027 for shareholder nominations and proposals.
- Added deadline for other director nominations or proposals: January 15 to February 12, 2027.
- Added deadline for proxy access nominations: January 15 to February 12, 2027.
- Added proxy access rules: shareholders owning 3%+ for 3 years can nominate up to 2 directors or 20% of board.
Removed
- Prior filing referenced quarter ended June 30, 2026; current references quarter ended September 30, 2026.
- Removed Exhibit 10.1 Solventum Executive Severance Plan (incorporated by reference to Form 8-K filed May 27, 2026).
- Removed Exhibit 10.2 Restricted Stock Unit Awards Agreement Two-Year Cliff Vesting (filed herewith).
- Removed Exhibit 10.3 Restricted Stock Unit Awards Agreement Two-Year Ratable Vesting (filed herewith).
- Removed Exhibit 10.4 Restricted Stock Unit Awards Agreement Three-Year Ratable Vesting (filed herewith).
Everything here comes from Solventum Corp's own filings on SEC EDGAR. The filing list is rechecked every hour. SECSift analysis was completed on Nov 5, 2026, from the 10-Q for Sep 2026.